Circumventing Immune Tolerance Through Epigenetic Modification

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|3|268-276

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.3, 2010-01, pp. : 268-276

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epigenetic Modification in Neuropathic Pain

By  

Current Pharmaceutical Design, Vol. 21, Iss. 7, 2015-02 ,pp. : 849-867

Bentham Science Publishers

Access to resources Recommend Favorite

Immune Tolerance Therapy for Haemophilia

By Ho A.Y.L.   Height S.E.   Smith M.P.  

Drugs, Vol. 60, Iss. 3, 2000-09 ,pp. : 547-554

Adis International

Access to resources Recommend Favorite

Liver Tolerance and the Manipulation of Immune Outcomes

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 7, Iss. 1, 2008-03 ,pp. : 6-18

Bentham Science Publishers

Access to resources Recommend Favorite

Epigenetic Modification Restores Functional PR Expression in Endometrial Cancer Cells

By  

Current Pharmaceutical Design, Vol. 20, Iss. 11, 2014-04 ,pp. : 1874-1880

Bentham Science Publishers

Access to resources Recommend Favorite

Immune tolerance induction preferred for haemophilia patients with inhibitors

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 282, 2000-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite